Neuropathic Pain clinical trials at University of California Health

2 in progress, 1 open to eligible people

Showing trials for

  • Cannabis Derivatives in Neuropathic Pain

    open to eligible people ages 21 years and up

    Chronic neuropathic pain (CNP) is disabling. Research on frontline treatments for CNP, shows inconsistent outcomes and dissatisfaction among Veterans. Veterans and clinicians have shown significant interest in cannabis derivatives (THC, CBD) for neuropathic pain control, but there are no well-controlled trials guiding expectations for benefit and adverse outcomes associated with cannabis for CNP. Because Veterans are likely to present with pain and pain-related polymorbidity significantly differing from that of civilians, a well-structured clinical trial of cannabinoids for Veterans with CNP is vital.

    at UCSD

  • Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA)

    Sorry, currently not accepting new patients, but might later

    This study is designed to measure how common nerve abnormalities are within a group of patients who feel discomfort within their eyes.

    at UCSF

Last updated: